Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Journal of Clinical Pathology|October 30, 2007
Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancerJ W Assender, J M W Gee, I Lewis, et al.
Clinical Breast Cancer|December 3, 2014
A good drug made better: the fulvestrant dose-response storyJohn F R Robertson, Justin Lindemann, Sally Garnett, et al.
Endocrine-Related Cancer|August 23, 2005
Development of strategies for the use of anti-growth factor treatmentsH E Jones, J M W Gee, K M Taylor, et al.
Reviews in Endocrine & Metabolic Disorders|May 9, 2007
Growth factor signalling in endocrine and anti-growth factor resistant breast cancerR I Nicholson, I R Hutcheson, H E Jones, et al.
International Journal of Cancer|July 17, 2015
Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsiesAmit Agrawal, John F R Robertson, Kwok L Cheung, et al.
Breast Cancer Research and Treatment|October 9, 2003
Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cellsIain R Hutcheson, Janice M Knowlden, Tracie-Ann Madden, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2006
Effects of fulvestrant 250mg in premenopausal women with oestrogen receptor-positive primary breast cancerJ F R Robertson, V Semiglazov, G Nemsadze, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|April 21, 2015
Interaction of biomechanics with extracellular matrix components in abdominal aortic aneurysm wallF Tanios, M W Gee, J Pelisek, et al.
Pageof 7